Watch Your Health has announced the completion of a $5 million funding round led by Cornerstone Ventures from India and Conquest Global from Singapore . This capital raise will help the company scale operations and expand the user base both domestically and internationally by growing
The First Indo-Uzbek Pharma Business Forum was successfully held in Hyderabad, Telangana, focusing on trade and investment opportunities in the pharmaceutical sector between India and Uzbekistan. This landmark event was jointly organized by the Embassy of Uzbekistan in New Delhi, the Pharmaceutical Industry Development Agency
The UNICEF order for ceftriaxone supply is an endorsement of Venus Remedies’ exceptional quality standards and its position as a trusted partner in global healthcare supply chains The company also secures a mandate from the world's oldest international public health agency for supplying essential
Wanbury Ltd, one of India’s fast growing pharmaceutical company having a presence in API global market and domestic branded formulation today announced the successful completion of the United States Food & Drug Administration (USFDA) inspection at Patalganga site, Maharashtra. The inspection that started from Monday,
Spearheading the shift towards Pharma 4.0 by leveraging the power of digital Building future-ready pharmaceutical production and biotech facilities to accelerate sustainability, resilience, and, agility Harnessing digital technologies for reducing ~70% CO2 emissions An IoT-enabled solution focused on water conservation, process electrification, sustainability by
Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024.Srinivas Sadu, a seasoned professional with
Net Profit increased by 43% to INR 126 crores in Q4 FY24 and 35% to INR 553 crores in FY24 JB Chemicals & Pharmaceuticals ltd (JB Pharma), one of the fastest growing pharmaceutical companies in India, announced its financial results for the quarter and year ended
Wanbury Ltd., one of India’s fastest growing pharmaceutical company having a presence in API global market and domestic branded Formulation, announced its financial results for the fourth quarter and year ended March 31, 2024.Consolidated Q4 & FY24 Financial Highlights
Need to add 30 lakh new hospital beds; aim to reach 100% health insurance coverage to achieve India’s healthcare vision 2047Mr Apurva Chandra, Secretary, Health & Family Welfare, Government of India today released the FICCI-EY report - ‘Decoding India’s Healthcare Landscape’. The report highlights
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market.(TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
